Xencor (XNCR) EBITDA Margin Growth (1y) (2014 - 2026)
Xencor (XNCR) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Xencor |
953.38 Mn |
878.64 Mn |
- |
-274,414.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-274,414.00 |
| Dec 31, 2025 |
6,191.00 |
| Sep 30, 2025 |
22,839.00 |
| Jun 30, 2025 |
21,888.00 |
| Mar 31, 2025 |
32,331.00 |
| Dec 31, 2024 |
-3,741.00 |
| Sep 30, 2024 |
-21,374.00 |
| Jun 30, 2024 |
-24,544.00 |
| Mar 31, 2024 |
-16,522.00 |
| Dec 31, 2023 |
-512.00 |
| Sep 30, 2023 |
8,433.00 |
| Jun 30, 2023 |
7,419.00 |
| Mar 31, 2023 |
-32,393.00 |
| Dec 31, 2022 |
-8,872.00 |
| Sep 30, 2022 |
8,108.00 |
| Jun 30, 2022 |
-19,584.00 |
| Mar 31, 2022 |
2,828.00 |
| Dec 31, 2021 |
8,040.00 |
| Sep 30, 2021 |
-16,645.00 |
| Jun 30, 2021 |
34,157.00 |
